Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Comparing apples and oranges in TRD treatment: the importance of assumptions in network meta-analysis
    Published on 2026-03-31
    6 months ago
  • Reply to mol: Comparing apples and oranges in TRD treatment: the importance of assumptions in network meta-analysis
    Published on 2026-03-31
    6 months ago
  • Correction: ACNP 64th Annual Meeting: Panels, Mini-Panels and Study Groups
    Published on 2026-03-26
    6 months ago
  • MDMA alters fear extinction, and reduces alcohol consumption in inbred alcohol preferring iP rats but not outbred Wistar rats
    Published on 2026-03-26
    6 months ago
  • It’s not all DAT: harnessing the potential of organic cation transporter 3 inhibition to selectively attenuate amphetamine reinforcement and dopamine release
    Published on 2026-03-25
    6 months ago
  • Contrasting roles of secondary motor cortex projections to the dorsolateral and dorsomedial striatum in incubation of cocaine-seeking
    Published on 2026-03-24
    6 months ago
  • Putative glymphatic function and free water in schizophrenia: A 7T DTI study across psychosis stages
    Published on 2026-03-23
    6 months ago
« Previous 1 … 23 24 25 26 27 … 143 Next »
Journal of Psychopharmacology
  • Landscape analysis of pre-registered clinical trials involving classical psychedelics
    Published on 2025-10-22
    11 months ago
  • Community-based causal evidence that high habitual caffeine consumption alters distinct polysomnography-derived sleep variables
    Published on 2025-10-19
    11 months ago
  • The effects of lithium on cognition in humans: A systematic review
    Published on 2025-10-17
    11 months ago
  • Effects of electroconvulsive shock on astroglial reactivity in a rat model of antipsychotic-induced neurotoxicity
    Published on 2025-10-16
    11 months ago
  • Mind the gap! Addressing unresolved aspects of abuse potential evaluation and scheduling of classic and novel psychedelic drugs
    Published on 2025-10-16
    11 months ago
  • A novel psychedelic 5-HT2A receptor agonist GM-2505: The pharmacokinetic, safety, and pharmacodynamic profile from a randomized trial healthy volunteer
    Published on 2025-10-16
    11 months ago
  • β-blockers’ neuropsychiatric risks: Overlooked evidence?
    Published on 2025-10-10
    11 months ago
« Previous 1 … 23 24 25 26 27 … 154 Next »
European Neuropsychopharmacology
  • The genetics of treatment-resistant depression: controversies and perspectives
    Published on 2025-08-06
    1 year ago
  • Fifty years of pharmacotherapy for obsessive-compulsive disorder – A short reflection
    Published on 2025-08-06
    1 year ago
  • Editorial Board
    Published on 2025-07-25
    1 year ago
  • Therapygenetics: Serotonin transporter gene polymorphism (5-HTTLPR) is associated with behavioral treatment response to virtual exposure therapy in patients with spider phobia
    Published on 2025-07-16
    1 year ago
  • Extrapyramidal symptoms as early clinical predictors in first-episode schizophrenia and schizophreniform disorder: findings from the OPTiMiSE trial
    Published on 2025-07-13
    1 year ago
  • Inflammation–neurotrophin interplay and depression outcomes: authors’ reply
    Published on 2025-07-12
    1 year ago
  • Clinical predictors of treatment resistant depression
    Published on 2025-07-12
    1 year ago
« Previous 1 … 23 24 25 26 27 … 170 Next »

   Pharma Pub